| 000 | 01504 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516171159.0 | ||
| 264 | 0 | _c20140708 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1573-0646 | ||
| 024 | 7 |
_a10.1007/s10637-013-0019-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLandowski, Terry H | |
| 245 | 0 | 0 |
_aThe diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers. _h[electronic resource] |
| 260 |
_bInvestigational new drugs _cDec 2013 |
||
| 300 |
_a1616-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aOxazoles _xpharmacology |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aTubulin _xmetabolism |
| 650 | 0 | 4 |
_aTubulin Modulators _xpharmacology |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aSamulitis, Betty K | |
| 700 | 1 | _aDorr, Robert T | |
| 773 | 0 |
_tInvestigational new drugs _gvol. 31 _gno. 6 _gp. 1616-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10637-013-0019-8 _zAvailable from publisher's website |
| 999 |
_c23089295 _d23089295 |
||